HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kentaro Sugi Selected Research

2- (2- (2- dimethylaminothiazol- 5- yl)ethenyl)- 6- (2- (fluoro)ethoxy)benzoxazole

8/2013A 18F-labeled BF-227 derivative as a potential radioligand for imaging dense amyloid plaques by positron emission tomography.
1/2010Voxel-based analysis of amyloid positron emission tomography probe [C]BF-227 uptake in mild cognitive impairment and alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kentaro Sugi Research Topics

Disease

2Alzheimer Disease (Alzheimer's Disease)
08/2013 - 01/2010
2Amyloid Plaque
08/2013 - 01/2010
1Cognitive Dysfunction
01/2010

Drug/Important Bio-Agent (IBA)

22- (2- (2- dimethylaminothiazol- 5- yl)ethenyl)- 6- (2- (fluoro)ethoxy)benzoxazoleIBA
08/2013 - 01/2010
2Amyloid (Amyloid Fibrils)IBA
08/2013 - 01/2010
1BenzoxazolesIBA
08/2013